SmartLabs provides resourced, enterprise-scale laboratory environments and resourcing solutions, including multifunctional R&D spaces, vivariums, process development and pilot-scale suites, and cGMP capacity under one roof. The company operates facilities on both the East and West Coasts to support companies of all stages and sizes. Its offering is designed to let customers launch, scale, and shift as programs and projects evolve by co-locating R&D infrastructure with manufacturing solutions. That co-location is intended to facilitate collaboration and improve access between R&D and manufacturing players. SmartLabs recently raised capital and plans to use the proceeds to expand operations and broaden its business reach. No revenue or user metrics were provided in the article. SmartLabs provides flexible, tech-enabled lab and office spaces (LaaS) that are customizable for research groups from fewer than 10 to more than 200 people and include multifunctional R&D spaces, vivariums, process development and pilot-scale suites, and cGMP capacity. The company bundles infrastructure, services, and a proprietary operating platform (SmartLabs OS) to let tenant companies launch, scale, and shift programs rapidly without sacrificing IP. In September the company launched SmartLabs OS v4.0, expanding a platform first introduced in 2016. SmartLabs operates four locations in Massachusetts (Kendall Square, East Cambridge, Boston Landing, Seaport) and one location in South San Francisco. The company says member teams can save as much as 45% in the first three years by using its integrated resources and that its centers support dozens of programs across cell and gene therapies and personalized genomic medicine. SmartLabs plans to use new funding to accelerate growth and scale operations to 2 million square feet within five years.

Total raised

$298M

Funding rounds

2

Latest round

Series C

Latest activity

Jan 2024